NEXTECH INVEST LTD.
Adviser information for NEXTECH INVEST LTD. last updated from Form ADV on March 29th, 2024. Select data displayed; additional Form ADV, Form D, Form 13F and other data is available from the Fincoded API.
Advisory Business
| Type of Organization | Other (specify) |
|---|---|
| Fiscal Year End | DECEMBER |
| Legal Location | Switzerland |
Employees
| Total Number of Employees | 0 |
|---|---|
| Investment Advisory/Research | 0 |
| Registered Broker-Dealer Representatives | 0 |
| Registered State Investment Advisers | 0 |
| Licensed Agents of an Insurance Company | 0 |
| No. of Firms/People that Solicit Clients | 0 |
RAUM
| Provides Management of Securities Portfolios | No |
|---|
Clients
| Type | Number | RAUM |
|---|---|---|
| Individuals | 0 | $0 |
| HNW Individuals | 0 | $0 |
| Banking or thrift institutions | 0 | $0 |
| Investment companies | 0 | $0 |
| Business development companies | 0 | $0 |
| Pooled investment vehicles | 0 | $0 |
| Pension and profit sharing plans | 0 | $0 |
| Charitable organizations | 0 | $0 |
| State or municipal gov entities | 0 | $0 |
| Other investment advisers | 0 | $0 |
| Insurance companies | 0 | $0 |
| Sovereign wealth funds and foreign official institutions | 0 | $0 |
| Corporations or other businesses | 0 | $0 |
| Other | 0 | $0 |
| Type | Number |
|---|---|
| No. of Non-RAUM Clients | 0 |
| No. of Non-U.S. Clients | 0 |
Services
| Advisory Services | – |
|---|---|
| Compensation | – |
Principal Office
BAHNHOFSTRASSE 18ZURICH
Switzerland
Monday - Friday, 08:00 - 17:00
Tel: +41 (0)44 366 66 11, Fax: None
Chief Compliance Officer
MARCO WEIBEL
CFO
BAHNHOFSTRASSE 18
ZURICH
Switzerland
Tel:
41443666616
W*****@****************M
(Full email address available in API data)
Industry Affiliates
| NEXTECH CROSSOVER I GP S.A R.L. | Sponsor, GP, manager of pooled investment vehicles |
| NEXTECH VENTURES (US) LLC | Other investment adviser, including financial plannersSponsor, GP, manager of pooled investment vehicles |
| NEXTECH VI GP S.A R.L. | Sponsor, GP, manager of pooled investment vehicles |
| NEXTECH VII GP S.A R.L. | Sponsor, GP, manager of pooled investment vehicles |
Private Funds
| Name | Type | Assets $USD | Min Investment $USD | No. Owners |
|---|---|---|---|---|
| NEXTECH CROSSOVER I SCSP | Private Equity Fund | $373.0M | $5.0M | 92 |
| NEXTECH VI ONCOLOGY SCSP | Private Equity Fund | $342.8M | $2.0M | 104 |
| NEXTECH VII ONCOLOGY SCSP | Private Equity Fund | $453.3M | $5.0M | 94 |
Control Persons
| Name | Type | Entity | Title | Since | Ownership |
|---|---|---|---|---|---|
| NEXTECH HOLDING AG | Foreign Entity | – | DIRECT OWNER | 03/2018 | 10-25% |
| HEADLAND HOLDING AG | Foreign Entity | – | DIRECT OWNER | 03/2018 | 25-50% |
| CLARENDON CAPITAL AG | Foreign Entity | – | DIRECT OWNER | 03/2018 | 25-50% |
| STATION STREET HOLDINGS AG | Foreign Entity | – | DIRECT OWNER | 03/2018 | 10-25% |
| WEIBEL, MARCO, CHRISTIAN | Individual | – | CHIEF COMPLIANCE OFFICER AND CHIEF FINANCIAL OFFICER | 03/2018 | < 5% |
| SCHEIDEGGER, ALFRED | Individual | – | MANAGING PARTNER | 03/2018 | < 5% |
| SCHROEDER, THILO | Individual | – | MANAGING PARTNER | 03/2018 | < 5% |
| LOVEN, JAKOB | Individual | – | MANAGING PARTNER | 03/2018 | < 5% |
| SCHEIDEGGER, ALFRED | Individual | NEXTECH HOLDING AG | OWNER | 03/2018 | > 75% |
| SCHROEDER, THILO | Individual | HEADLAND HOLDING AG | OWNER | 03/2018 | > 75% |
| LOVEN, JAKOB | Individual | CLARENDON CAPITAL AG | OWNER | 03/2018 | > 75% |
| SGOBBO, ROCCO, JOSEPH | Individual | – | MANAGING PARTNER AND CHIEF OPERATING OFFICER | 03/2018 | < 5% |
| SGOBBO, ROCCO, JOSEPH | Individual | STATION STREET HOLDINGS AG | OWNER | 03/2018 | > 75% |
No. Employees, Historic
Holdings
From latest 13F, filed August 14th, 2024 for period ending June 30th, 2024
| Name | Class | Value $USD | # Shares | Private Fund |
|---|---|---|---|---|
| ARS PHARMACEUTICALS INC | COM | 16M | 2M | – |
| ARVINAS INC | COM | 37M | 1M | – |
| BOUNDLESS BIO INC | COM | 5M | 1M | – |
| CARGO THERAPEUTICS INC | COM | 43M | 3M | – |
| CONTEXT THERAPEUTICS INC | COM | 15M | 7M | – |
| CULLINAN ONCOLOGY INC | COM | 21M | 1M | – |
| MERSANA THERAPEUTICS INC | COM | 19M | 10M | – |
| ORIC PHARMACEUTICALS INC | COM | 37M | 5M | – |
| RELAY THERAPEUTICS INC | COM | 25M | 4M | – |
| REVOLUTION MEDICINES INC | COM | 244M | 6M | – |
| SILENCE THERAPEUTICS PLC | ADS | 18M | 952K | – |
| TANGO THERAPEUTICS INC | COM | 47M | 6M | – |
| TYRA BIOSCIENCES INC | COM | 65M | 4M | – |